Dexamfetamine, a regulated substance, is utilized in Australia primarily for the management of Attention-Deficit/Hyperactivity Disorder (ADHD) and, less often, narcolepsy. Administration is strictly monitored under the Therapeutic Goods Act and requires a valid prescription from an Australian regist